Hereditary Spastic Paraparesis: A Review of New Developments
JNNP 69:150-160, McDermott,C.J. et al, 2000
Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000
Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke
JAMA 284:465-471, Perry,Jr.,H.M. et al, 2000
Anticonvulsant Prophylaxis and Timing of Seizures After Aneurysmal Subarachnoid Hemorrhage
Neurol 55:258-265, Rhoney,D.H. et al, 2000
Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000
Low-Molecular-Weight heparins and Heparinoids in Acute ischemic Stroke
Stroke 31:1770-1778, Bath,P.M.W. et al, 2000
Assessment of lacunar hemorrhage Associated With Hypertensive Stroke by Echo-Planar Gradient-Echo T2-Weighted MRI
Stroke 31:1646-1650, Kinoshita,T. et al, 2000
Deep Brain Stimulation of Subthalamic Area for Severe Proximal Tremor
Neurol 55:114-116, Kitagawa,M. et al, 2000
Family History and DNA Analysis in Patients With Suspected Huntington's Disease
JNNP 69:54-59, Siesling,S. et al, 2000
Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000
Clinical Subtypes of Essential Tremor
Arch Neurol 57:1194-1198, Louis,E.D. et al, 2000
Long-term Effect of Bone-marrow Transplantation for Childhood-onset Cerebral X-linked Adrenoleukodystrophy
Lancet 356:713-718, Shapiro,E. et al, 2000
Evolution of Sporadic Olivopontocerebellar Atrophy Into Multiple System Atrophy
Neurol 55:527-532, Gilman,S. et al, 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Abnormal White Matter Signal in Ataxia Telangiectasia
AJNR 21:1483-1485, Ciemins,J.J. & Horowitz,A.L., 2000
Health Outcomes 1 Year After Subarachonid Hemorrhage
Neurol 55:658-662, Hackett,M.L. et al, 2000
Spinocerebellar Ataxia Type 8
Neurol 55:649-657, Day,J.W. et al, 2000
Hydrocephalus Is a Determinant of Early Mortality in Putaminal Hemorrhage
Stroke 31:2157-2162, Phan,T.G. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000
Avoiding Pitfalls in the Diagnosis of Subarachnoid Hemorrhage
NEJM 342:29-36, Edlow,J.A.&Caplan,L.R., 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Pure Sensory Stroke Caused by a Cerebral Hemorrhage: Clinical-Radiologic Correlations in Seven Patients
AJNR 21:515-520, Shintani,S.,et al, 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Effect of Liver Transplantation on Neurological Manifestations in Wilson Disease
ArchNeurol 57:384-386, Stracciari,A.,et al, 2000
Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
NEJM 342:770-780, Dalakas,M.C.,et al, 2000
Antifibrinolytic Treatment in Subarachnoid Hemorrhage, A Randomized Placebo-Controlled Trial
Neurol 54:77-82, Roos,Y.,STAR Study Group, 2000
Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage, A Randomized Controlled Trial
Stroke 31:383-391, Lennihan,L.,et al, 2000
Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral Hemorrhage
NEJM 342:240-245,276, O'Donnell,H.C.,et al, 2000
Rate of Stroke Recurrence in Patients with Primary Intracerebral Hemorrhage
Stroke 31:123-127, Hill,M.D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Identifying Stroke in the Field, Prospective Validation of the Los Angeles Prehospital Stroke Screen (LAPSS)
Stroke 31:71-76, Kidwell,C.S.,et al, 2000
Incidence and Prognostic Significance of Fever Following Intracerebral Hemorrhage
Neurol 54:354-361, Schwarz,S.,et al, 2000
A Locus for Paroxysmal Kinesigenic Dyskinesia Maps to Human Chromosome 16
Neurol 54:125-130, Bennett,L.B.,et al, 2000
A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000
The Brain Code in Health and Disease
Arch Neurol 57:50-51, Rosenberg,R.N., 2000
Autosomal Dominant Diffuse Leukoencephalopathy with Neuroaxonal Spheroids
Neurol 54:463-468, van der Knaap,M.S.,et al, 2000
Congenital Muscular Dystrophy with Rigid Spine Syndrome:A Clinical, Pathological, Radiological, and Genetic Study
Ann Neurol 47:152-161, 143, Flanigan,K.M.,et al, 2000
Hereditary Recurrent Focal Neuropathies, Clinical and Molecular Features
Neurol 54:546-551, Stogbauer,F.,et al, 2000
Childhood Head Injuries, Accidental or Inflicted?
Arch Pediatr Adolesc Med 154:11-15, Reece,R.M.&Sege,R., 2000
Diffuse Vasospasm after Pretruncal Nonaneurysmal Subarachnoid Hemorrhage
AJNR 21:521-523, Schievink,W.I.,et al, 2000
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Distribution of Cranial MRI Abnormalities in Patients with Symptomatic and Subclinical CADASIL
BJR 73:256-265, Coulthard, A.,et al, 2000
Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000
Familial Neuromyelitis Optica (Devics Syndrome) with Late Onset in Japan
Neurol 55:318-320, Yamakawa,K.,et al, 2000
Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999